KADCYLA can be used after surgery for people with HER2+ early
breast cancer:
- who received
treatment before surgery that included a taxane and trastuzumab
(Herceptin®) and
- who had
surgery and their cancer remained in the tissue that was
removed
HER2+: HER2 stands for human epidermal growth factor receptor 2.
Financial Resources

If you need help paying for KADCYLA, there may be options to
help.
Taking KADCYLA

Understand how KADCYLA is given for early breast cancer.
Starting the conversation

Questions to ask your doctor before and during treatment with KADCYLA.